Peter Priester Selected Research

Ma2 antigen

9/2018

Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Priester Research Topics

Disease

2	Neoplasms (Cancer) 12/2023 - 01/2012
1	Malnutrition (Nutritional Deficiencies) 12/2023
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Melanoma (Melanoma, Malignant) 12/2022
1	Brain Diseases (Brain Disorder) 09/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2018
1	Chorea (Rheumatic Chorea) 09/2018
1	Encephalitis (Encephalitis, Rasmussen) 09/2018
1	Kidney Neoplasms (Kidney Cancer) 09/2018
1	Dyskinesias (Dyskinesia) 09/2018
1	Breast Neoplasms (Breast Cancer) 12/2010
1	Cardiac Arrhythmias (Arrythmia) 12/2010
1	Glioblastoma (Glioblastoma Multiforme) 08/2010
1	Aplastic Anemia (Anemia, Hypoplastic) 08/2010

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 12/2022 - 09/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022
1	Ma2 antigenIBA 09/2018
1	NivolumabIBA 09/2018
1	AutoantibodiesIBA 09/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2010
1	Tamoxifen FDA LinkGeneric 12/2010
1	Temozolomide (Temodar)FDA LinkGeneric 08/2010

Therapy/Procedure

2	Palliative Care (Palliative Therapy) 12/2023 - 01/2012
2	Therapeutics 12/2022 - 09/2018
1	Nutritional Support (Artificial Feeding) 12/2023
1	Immunotherapy 12/2022
1	Hospice Care (Care, Bereavement) 01/2012
1	Aftercare (After-Treatment) 01/2012
1	Radiotherapy 08/2010
1	Chemoradiotherapy 08/2010
1	Drug Therapy (Chemotherapy) 08/2010